Mikhail Blagosklonny is a renowned expert in aging and cancer. He is also an oncology professor and has been hired by the Roswell Park Cancer Institute. Blagosklonny schooled at the First Pavlov State Medical University of St. Petersburg where he got a master’s degree in internal medicine. He also pursued his Ph.D. in experimental medicine and cardiology at the university. The New York Medical College offered Mikhail an opportunity to serve it as an associate professor as from 2002. After a while, he was hired by the Ordway Research Institute and acted as a senior scientist. The professor of oncology began his career at the Roswell Park Cancer Institute in 2009. The wealth of experience that he earned from his former employers has allowed him to offer excellent services to the institution. The main areas where Mikhail has focused on include biogerontology, anti-aging drugs, cancer, and different targeted cancer therapies that are not harmful to healthy body cells.
The professor acts as an editor in chief at Oncotarget and Cell Cycle. He has also been offered a chance to be therapy and cancer biology’s associate editor. Mikhail has been privileged to be one of the professionals who sit on the Cell Death and Differentiation’s editorial board. He has come up with a hypothesis that explains the use of TOR signaling potential in addressing cancer and aging issues. He has been advising people to use Rapamycin, which has been recognized as one of the best cancer treatments. Mikhail has been involved in the longevity research of Rapamycin. The areas where he has conducted research include cellular biology, clinical investigations, and molecular biology. His work has focused on drug resistance, tumor suppressors, ontogenesis, mitosis, apoptosis, anticancer therapeutics, and signal transduction.Blagosklonny currently owns a lot of written work that discusses the aging hyperfunction theory. Examples of the topics that the professor talks about include cyclotherapy engineering and cell chemotherapeutic. The oncology research that he has done has enabled him to gain international recognition.
According to Mikhail, medical practitioners can treat conditions like aging and cancer. He believes it possible to cure cancer by using Rapamycin. Throughout his career, the professor has completed more than 300 reviews, research articles, and book chapters. PLoS ONE, the American Journal of Pathology, and International Journal of Cancer have hired him to act as an associate editor. Blagosklonny’s hard work and commitment to his career have enabled him to be one of leading professionals in the oncology research world. According to him, his profession as an oncology expert was inspired by his love for human life and dedication to making the world a disease-free place.The outstanding work of the professor has made him be appreciated by the Roswell Park Cancer Institute for the past eight years that he has served it. The institution provides an ideal platform for professionals to share their ideas on how cancer can be eliminated. It has developed an approach that can be used in preventing aging by curing cancer.